Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Tiberi

Showing results (41-50 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 2, 2020
A postgraduate qualification in tuberculosis-Message in a bottleSimon Tiberi, Alimuddin Zumla, Mario Raviglione, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 2, 2020
Non-tuberculous mycobacterial infections-A neglected and emerging problemImran Ahmed, Simon Tiberi, Joveria Farooqi, et al.
The European Respiratory Journal|June 9, 2018
QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) studyLorenzo Guglielmetti, Simon Tiberi, Matthew Burman, et al.
Journal of Thoracic Disease|November 22, 2016
Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectivesAdrian Rendon, Simon Tiberi, Anna Scardigli, et al.
International Journal of Molecular Sciences|March 18, 2016
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic ReviewGiovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, et al.
International Journal of Molecular Sciences|February 9, 2017
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic ReviewGiovanni Battista Migliori, Emanuele Pontali, Giovanni Sotgiu, et al.
The European Respiratory Journal|March 24, 2018
Renal Fanconi syndrome with meropenem-containing regimen in drug-resistant tuberculosisSimon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 9, 2025
Corrigendum to "Candidate anti-tuberculosis medicines and regimens under clinical evaluation" [Clin Microbiol Infect 30(9) (2024) 1131-1138]Michael Hoelscher, David Barros-Aguirre, Masoud Dara, et al.
Scientific Reports|August 4, 2023
Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot studyJeniffer Perussolo, Muy-Teck Teh, Nikolaos Gkranias, et al.
The European Respiratory Journal|September 28, 2013
ERS/WHO tuberculosis consilium: reporting of the initial 10 casesLia D'Ambrosio, Marina Tadolini, Stephane Dupasquier, et al.
Pageof 15

Showing results (41-50 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 2, 2020
A postgraduate qualification in tuberculosis-Message in a bottleSimon Tiberi, Alimuddin Zumla, Mario Raviglione, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 2, 2020
Non-tuberculous mycobacterial infections-A neglected and emerging problemImran Ahmed, Simon Tiberi, Joveria Farooqi, et al.
The European Respiratory Journal|June 9, 2018
QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) studyLorenzo Guglielmetti, Simon Tiberi, Matthew Burman, et al.
Journal of Thoracic Disease|November 22, 2016
Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectivesAdrian Rendon, Simon Tiberi, Anna Scardigli, et al.
International Journal of Molecular Sciences|March 18, 2016
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic ReviewGiovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, et al.
International Journal of Molecular Sciences|February 9, 2017
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic ReviewGiovanni Battista Migliori, Emanuele Pontali, Giovanni Sotgiu, et al.
The European Respiratory Journal|March 24, 2018
Renal Fanconi syndrome with meropenem-containing regimen in drug-resistant tuberculosisSimon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 9, 2025
Corrigendum to "Candidate anti-tuberculosis medicines and regimens under clinical evaluation" [Clin Microbiol Infect 30(9) (2024) 1131-1138]Michael Hoelscher, David Barros-Aguirre, Masoud Dara, et al.
Scientific Reports|August 4, 2023
Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot studyJeniffer Perussolo, Muy-Teck Teh, Nikolaos Gkranias, et al.
The European Respiratory Journal|September 28, 2013
ERS/WHO tuberculosis consilium: reporting of the initial 10 casesLia D'Ambrosio, Marina Tadolini, Stephane Dupasquier, et al.
Pageof 15